Related references
Note: Only part of the references are listed.Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia
Arne Kristian Schwarz et al.
ANNALS OF HEMATOLOGY (2009)
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas
S. Hohaus et al.
ANNALS OF ONCOLOGY (2009)
The presence of circulating total DNA and methylated genes is associated with circulating tumour cells in blood from breast cancer patients
I. Van der Auwera et al.
BRITISH JOURNAL OF CANCER (2009)
Cell-free Tumor DNA in Blood Plasma As a Marker for Circulating Tumor Cells in Prostate Cancer
Heidi Schwarzenbach et al.
CLINICAL CANCER RESEARCH (2009)
IGH and IGK gene rearrangements as PCR targets for pediatric Burkitt's lymphoma and mature B-ALL MRD analysis
Federica Lovisa et al.
LABORATORY INVESTIGATION (2009)
Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer/T-cell lymphoma
Hyo Song Kim et al.
LEUKEMIA & LYMPHOMA (2009)
Burkitt Lymphoma in Brazil Is Characterized by Geographically Distinct Clinicopathologic Features
Eduardo M. Queiroga et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Plasma Epstein-Barr viral load predicting response after chemotherapy for post-transplant lymphoproliferative disease
Alex Sandro C. Machado et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2008)
Circulating DNA: a potential marker of sickle cell crisis
Nisha Vasavda et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development
DM Weinstock et al.
BONE MARROW TRANSPLANTATION (2006)
Plasma Epstein-Barr virus (EBV) DNA is a biomarker for EBV-positive Hodgkin's lymphoma
MK Gandhi et al.
CLINICAL CANCER RESEARCH (2006)
Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
RM Bremnes et al.
LUNG CANCER (2005)
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia
A Rogers et al.
BLOOD (2004)
Improved accuracy of detection of nasopharyngeal carcinoma by combined application of circulating Epstein-Barr virus DNA and anti-Epstein-Barr viral capsid antigen IgA antibody
SF Leung et al.
CLINICAL CHEMISTRY (2004)
Treatment of children with B-cell non-Hodgkin's lymphoma in developing countries: The experience of a single center in Brazil
CE Klumb et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)
Quantification of circulating Epstein-Barr virus (EBV) DNA in the diagnosis and monitoring of natural killer cell and EBV-positive lymphomas in immunocompetent patients
WY Au et al.
BLOOD (2004)
Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma
JC Lin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Geographic variation in Epstein-Barr virus-associated Burkitt's lymphoma in children from Brazil
CE Klumb et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Epstein-Barr virus (EBV) DNA in plasma is not encapsidated in patients with EBV-related malignancies
JL Ryan et al.
DIAGNOSTIC MOLECULAR PATHOLOGY (2004)
Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy
O Gautschi et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Burkitt's and Burkitt-like lymphoma in children and adolescents: a review of the Children's Cancer Group Experience
MS Cairo et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Circulating nucleic acids in plasma and serum as a noninvasive investigation for cancer: Time for large-scale clinical studies?
P Anker et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Circulating DNA: a new diagnostic gold mine?
A Ziegler et al.
CANCER TREATMENT REVIEWS (2002)
Quantitative analysis of circulating cell-free Epstein-Barr virus (EBV) DNA levels in patients with EBV-associated lymphoid malignancies
KIK Lei et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)